SCHEMBL9104313

SCHEMBL9104313

Cc1ccc2c(c1)CC(=O)N2C(CC(C)C)C(=O)Nc1ccccn1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.42
LMNA P02545 2/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 3/20 0.42
GCK P35557 3/20 0.41
POLB P06746 1/20 0.41
NPC1 O15118 3/20 0.41
PDE5A O76074 1/20 0.40
MMP1 P03956 2/20 0.39
MMP3 P08254 2/20 0.39
MMP9 P14780 2/20 0.39
SHMT2 P34897 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
USP2 O75604 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9105915 0.90 FFAR2 (0.45) RAB9ALMNAALDH1A1KDM4EGCK
SCHEMBL9107559 0.90 RAB9A (0.41) RAB9ALMNAALDH1A1KDM4EGCK
SCHEMBL9104726 0.89 LMNA (0.45) RAB9ALMNAALDH1A1KDM4EGCK
SCHEMBL9103283 0.88 F2 (0.42) RAB9ALMNAALDH1A1KDM4EGCK
SCHEMBL9908105 0.88 RAB9A (0.43) RAB9AKDM4EGCKPOLBNPC1
SCHEMBL9108970 0.88 RAB9A (0.43) RAB9AKDM4EGCKPOLBNPC1
SCHEMBL9103261 0.85 GCK (0.53) KDM4EGCKTSHR
SCHEMBL9107671 0.85 RAB9A (0.38) RAB9ALMNAALDH1A1KDM4EGCK
SCHEMBL9103205 0.84 FFAR2 (0.45) RAB9ALMNAALDH1A1KDM4EGCK
SCHEMBL9908104 0.83 NPC1 (0.41) RAB9ALMNAALDH1A1KDM4EGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US claimed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT RAB9A 1778/4885LMNA 4226/4885ALDH1A1 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.